top of page
Corporate Update on Clinical Evaluation of MedMira’s Products
Halifax, Nova Scotia,1 February, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to provide an update on the ongoing review...
MedMira
Feb 1, 20243 min read
U.S. FDA Approves MedMira’s Advanced Reveal® G4 Rapid HIV-1/2 Antibody Test
Halifax, Nova Scotia, 13 December, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) MedMira Inc. proudly announces today the successful...
MedMira
Dec 14, 20233 min read
FY2023 Update
Corporate Update Throughout the reporting period, the Company achieved significant milestones in its pursuit of FDA and Health Canada...
MedMira
Nov 29, 20232 min read
Update on MedMira’s Regulatory Path in Canada and the USA
Halifax, Nova Scotia, 27 September, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its progress to achieve...
MedMira
Sep 27, 20233 min read
Finger-Prick Test Developed For ‘Trich’ A Common, Undiagnosed STI
https://scienceblog.com/537081/finger-prick-test-developed-for-trich-a-common-undiagnosed-sti/ A quick, affordable diagnostic test...
MedMira
Mar 29, 20232 min read
MedMira receives 3 new trademarks
MedMira has been notified that the Company has successfully defended its claim on its submitted trademarks. VYRA U.S. Serial Number:...
MedMira
Mar 24, 20231 min read
bottom of page